Photodynamic therapy and photodiagnosis for Barrett's oesophagus and early oesophageal carcinoma

Photodiagnosis and Photodynamic Therapy

Volumn 1, Issue 4, 2004, Pages 319-334

  Mitton, D ^a   Claydon, P ^a   Ackroyd, R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Oesophageal carcinoma; Photodiagnosis; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; HEMATOPORPHYRIN DERIVATIVE; METHYLENE BLUE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN;

ADVANCED CANCER; BARRETT ESOPHAGUS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER SURGERY; CLINICAL TRIAL; DOSIMETRY; DRUG SAFETY; EPITHELIUM DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS DILATATION; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; ESOPHAGUS STRICTURE; FLUORESCENCE SPECTROSCOPY; GASTROESOPHAGEAL REFLUX; HEALTH PROGRAM; HUMAN; MALIGNANT TRANSFORMATION; NAUSEA; NEODYMIUM LASER; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PLEURA EFFUSION; PRIORITY JOURNAL; RECOGNITION; RECURRENT CANCER; REVIEW; SIDE EFFECT; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; STOMACH MUCOSA LESION; STOMACH TUMOR; SUPERFICIAL CANCER; THORAX DRAINAGE; TRACHEOESOPHAGEAL FISTULA; VOMITING;

EID: 16244372734     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(05)00009-8     Document Type: Review

References (106)

1. N.R. Barrett Chronic peptic ulcer of the oesophagus and "oesophagitis" Br J Surg 38 1950 175 182
2. A. Watson Barrett's oesophagus - 50 years on Br J Surg 87 5 2000 529 531
3. R.C. Haggitt Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 10 1994 982 993
4. S.M. Dresner, S.M. Griffin, and J. Wayman Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia Br J Surg 90 9 2003 1120 1128
5. J.W. van Sandick, J.J. van Lanschot, and B.W. Kuiken Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut 43 2 1998 216 222
6. M. Miros, P. Kerlin, and N. Walker Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus Gut 32 12 1991 1441 1446
7. A.J. Cameron, A.R. Zinsmeister, and D.J. Ballard Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings Gastroenterology 99 4 1990 918 922
8. A.J. Cameron Epidemiology of Barrett's esophagus and adenocarcinoma Dis Esophagus 15 2 2002 106 108
9. J. van den Boogert, R. van Hillegersberg, and R.W. de Bruin Barrett's oesophagus: pathophysiology, diagnosis, and management Scand J Gastroenterol 33 5 1998 449 453
10. W. Hameeteman, G.N. Tytgat, and H.J. Houthoff Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 5 Pt 1 1989 1249 1256
11. A.P. Burke, L.H. Sobin, and K.M. Shekitka Dysplasia of the stomach and Barrett esophagus: a follow-up study Mod Pathol 4 3 1991 336 341
12. N.S. Buttar, K.K. Wang, and T.J. Sebo Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 7 2001 1630 1639
13. E.M. van Lieshout, J.B. Jansen, and W.H. Peters Biomarkers in Barrett's esophagus (review) Int J Oncol 13 4 1998 855 864
14. S.S. Devesa, W.J. Blot, and J.F. Fraumeni Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 10 1998 2049 2053
15. J.T. Wei, and N. Shaheen The changing epidemiology of esophageal adenocarcinoma Semin Gastrointest Dis 14 3 2003 112 127
16. J.M. Muller, H. Erasmi, and M. Stelzner Surgical therapy of oesophageal carcinoma Br J Surg 77 8 1990 845 857
17. R. Earlam, and J.R. Cunha-Melo Oesophageal squamous cell carcinoma: I. A critical review of surgery Br J Surg 67 6 1980 381 390
18. G.G. Jamieson, G. Mathew, and R. Ludemann Postoperative mortality following oesophagectomy and problems in reporting its rate Br J Surg 91 8 2004 943 947
19. J. Deviere, M. Buset, and J.M. Dumonceau Regression of Barrett's epithelium with omeprazole N Engl J Med 320 22 1989 1497 1498
20. R.E. Sampliner Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus Am J Gastroenterol 89 10 1994 1844 1848
21. P. Sharma, R.E. Sampliner, and E. Camargo Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus Am J Gastroenterol 92 4 1997 582 585
22. D.L. Brand, J.T. Ylvisaker, and M. Gelfand Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery N Engl J Med 302 15 1980 844 848
23. P.M. Sagar, R. Ackroyd, and K.B. Hosie Regression and progression of Barrett's oesophagus after antireflux surgery Br J Surg 82 6 1995 806 810
24. M.L. McDonald, V.F. Trastek, and M.S. Allen Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg 111 6 1996 1135 1138 [discussion 1139-40]
25. R. Sampliner Antireflux surgery and Barrett's esophagus regression: wheel of fortune, or to tell the truth? Am J Gastroenterol 86 5 1991 645 646
26. R.E. Sampliner, B. Fennerty, and H.S. Garewal Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results Gastrointest Endosc 44 5 1996 532 535
27. K.R. Weishaupt, C.J. Gomer, and T.J. Dougherty Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor Cancer Res 36 7 Pt 1 1976 2326 2329
28. H. Inoue Treatment of esophageal and gastric tumors Endoscopy 33 2 2001 119 125
29. A.H. Holscher, E. Bollschweiler, and P.M. Schneider Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma Cancer 76 2 1995 178 186
30. A.H. Holscher, E. Bollschweiler, and W. Schroder Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus Dis Esophagus 10 3 1997 179 184
31. R. Lambert Endoscopic detection and treatment of early esophageal cancer: a critical analysis Endoscopy 27 1 1995 12 18 [discussion 58-9]
32. T.J. Dougherty An update on photodynamic therapy applications J Clin Laser Med Surg 20 1 2002 3 7
33. T. Okunaka, H. Kato, and C. Conaka Photodynamic therapy of esophageal carcinoma Surg Endosc 4 3 1990 150 153
34. H. Tajiri, N. Daikuzono, and S.N. Joffe Photoradiation therapy in early gastrointestinal cancer Gastrointest Endosc 33 2 1987 88 90
35. Y. Hayata, H. Kato, and H. Okitsu Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract Semin Surg Oncol 1 1 1985 1 11
36. B.F. Overholt, and M. Panjehpour Photodynamic therapy for Barrett's esophagus Gastrointest Endosc Clin N Am 7 2 1997 207 220
37. M.A. Laukka, and K.K. Wang Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus Gastrointest Endosc 42 1 1995 59 63
38. B.F. Overholt, R.C. DeNovo, and M. Panjehpour A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model Gastrointest Endosc 39 6 1993 782 787
39. M. Panjehpour, B.F. Overholt, and R.C. DeNovo Centering balloon to improve esophageal photodynamic therapy Lasers Surg Med 12 6 1992 631 638
40. B. Overholt, M. Panjehpour, and E. Tefftellar Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus Gastrointest Endosc 39 1 1993 73 76
41. L. Gossner, A. May, and R. Sroka A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia Endoscopy 31 5 1999 370 376
42. B.F. Overholt, and M. Panjehpour Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer Gastrointest Endosc 42 1 1995 64 70
43. B.F. Overholt, and M. Panjehpour Photodynamic therapy in Barrett's esophagus J Clin Laser Med Surg 14 5 1996 245 249
44. B.F. Overholt, M. Panjehpour, and J.M. Haydek Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients Gastrointest Endosc 49 1 1999 1 7
45. P. Grosjean, J.F. Savary, and J. Mizeret Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin J Clin Laser Med Surg 14 5 1996 281 287
46. B.F. Overholt, and M. Panjehpour Photodynamic therapy for Barrett's esophagus: clinical update Am J Gastroenterol 91 9 1996 1719 1723
47. M. Panjehpour, B.F. Overholt, and J.M. Haydek Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation Am J Gastroenterol 95 9 2000 2177 2184
48. T. Nakamura, H. Fukui, and K. Shirakawa Photodynamic therapy of superficial esophageal cancer with a transparent hood Gastrointest Endosc 60 1 2004 120 124
49. R.J. Thomas, M. Abbott, and P.S. Bhathal High-dose photoirradiation of esophageal cancer Ann Surg 206 2 1987 193 199
50. S.K. Heier, K.A. Rothman, and L.M. Heier Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy Gastroenterology 109 1 1995 63 72
51. The UK Clinical PDT Study Group. Clinical guidelines for performing photodynamic therapy (PDT) on patients with bronchopulmonary or oesophageal cancer; 2002.
52. M.I. Canto Methylene blue chromoendoscopy for Barrett's esophagus: coming soon to your GI unit? Gastrointest Endosc 54 3 2001 403 409
53. K. Egger, M. Werner, and A. Meining Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques Gut 52 1 2003 18 23
54. Q. Peng, T. Warloe, and K. Berg 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges Cancer 79 12 1997 2282 2308
55. H. Messmann, R. Knuchel, and W. Baumler Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization Gastrointest Endosc 49 1 1999 97 101
56. B. Mayinger, H. Reh, and J. Hochberger Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions Gastrointest Endosc 50 2 1999 242 246
57. E. Endlicher, R. Knuechel, and T. Hauser Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation Gut 48 3 2001 314 319
58. M.A. Ortner, B. Ebert, and E. Hein Time gated fluorescence spectroscopy in Barrett's oesophagus Gut 52 1 2003 28 33
59. T.J. Dougherty, M.T. Cooper, and T.S. Mang Cutaneous phototoxic occurrences in patients receiving Photofrin Lasers Surg Med 10 5 1990 485 488
60. H.I. Pass Photodynamic therapy in oncology: mechanisms and clinical use J Natl Cancer Inst 85 6 1993 443 456
61. M.E. Tian, S.L. Qui, and Q. Ji Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of early esophageal carcinoma Adv Exp Med Biol 193 1985 21 25
62. C.J. Lightdale, S.K. Heier, and N.E. Marcon Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial Gastrointest Endosc 42 6 1995 507 512
63. A. Sibille, R. Lambert, and J.C. Souquet Long-term survival after photodynamic therapy for esophageal cancer Gastroenterology 108 2 1995 337 344
64. P. Spinelli, A. Mancini, and M. Dal Fante Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy Semin Surg Oncol 11 4 1995 307 318
65. B.F. Overholt, M. Panjehpour, and D.L. Halberg Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results Gastrointest Endosc 58 2 2003 183 188
66. P. Hinnen, F.W. de Rooij, and M.L. van Velthuysen Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus Br J Cancer 78 5 1998 679 682
67. L. Gossner, M. Stolte, and R. Sroka Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid Gastroenterology 114 3 1998 448 455
68. R. Ackroyd, N.J. Brown, and T.J. Stephenson Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol 52 7 1999 509 512
69. H. Barr, N.A. Shepherd, and A. Dix Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX Lancet 348 9027 1996 584 585
70. L.R. Biddlestone, C.P. Barham, and S.P. Wilkinson The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy Am J Surg Pathol 22 2 1998 239 245
71. L. Gossner, A. May, and R. Sroka Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid Cancer 86 10 1999 1921 1928
72. R. Ackroyd, N.J. Brown, and M.F. Davis Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial Gut 47 5 2000 612 617
73. J.F. Savary, P. Monnier, and C. Fontolliet Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra(hydroxyphenyl) chlorin Arch Otolaryngol Head Neck Surg 123 2 1997 162 168
74. G. Wagnieres, C. Hadjur, and P. Grosjean Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin Photochem Photobiol 68 3 1998 382 387
75. S.A. Blant, T.M. Glanzmann, and J.P. Ballini Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study Br J Cancer 87 12 2002 1470 1478
76. S. Andrejevic Blant, P. Grosjean, and J.P. Ballini Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study J Photochem Photobiol B 61 1/2 2001 1 9
77. D.R. Braichotte, J.F. Savary, and P. Monnier Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy Lasers Surg Med 19 3 1996 340 346
78. M. Zellweger, P. Grosjean, and P. Monnier Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi Photochem Photobiol 69 5 1999 605 610
79. A. Radu, R. Conde, and C. Fontolliet Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model Gastrointest Endosc 57 7 2003 897 905
80. B. Javaid, P. Watt, and N. Krasner Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study Lasers Med Sci 17 1 2002 51 56
81. J.F. Savary, P. Grosjean, and P. Monnier Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases Endoscopy 30 3 1998 258 265
82. R. Bays, G. Wagnieres, and D. Robert Light dosimetry for photodynamic therapy in the esophagus Lasers Surg Med 20 3 1997 290 303
83. J. Etienne, N. Dorme, and G. Bourg-Heckly Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus Gastrointest Endosc 59 7 2004 880 889
84. R.M. Soetikno, T. Gotoda, and Y. Nakanishi Endoscopic mucosal resection Gastrointest Endosc 57 4 2003 567 579
85. N. Soehendra, K.F. Binmoeller, and S. Bohnacker Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique for resection of flat early cancer Endoscopy 29 5 1997 380 383
86. H. Inoue Endoscopic mucosal resection for esophageal and gastric mucosal cancers Can J Gastroenterol 12 5 1998 355 359
87. C. Ell, A. May, and L. Gossner Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus Gastroenterology 118 4 2000 670 677
88. N.S. Buttar, K.K. Wang, and L.S. Lutzke Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus Gastrointest Endosc 54 6 2001 682 688
89. D.G. Adler, and T.H. Baron Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients Am J Gastroenterol 97 2002 72 78
90. R. van Hillegersberg, J. Haringsma, and F.J. ten Kate Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus Dig Surg 20 5 2003 440 444
91. M.L. Jin, B.Q.Y Li, R. Li, and P.P. Li Analysis of haematoporphyrin derivative and laser photodynamic therapy of upper gastrointestinal tumours in 52 cases Lasers Med Sci 2 1987 51 54
92. F. Calzavara, L. Tomio, and L. Corti Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy J Photochem Photobiol B 6 1/2 1990 167 174
93. Y. Hayata Photodynamic Therapy of 168 Early Stage Cancers of the Lung and Oesophagus: A Japanese Multi-centre Study Lasers Med Sci 11 1996 255 259
94. J.S. McCaughan Jr., E.C. Ellison, and J.T. Guy Photodynamic therapy for esophageal malignancy: a prospective twelve-year study Ann Thorac Surg 62 4 1996 1005 1009 [discussion 1009-10]
95. M.A. Ortner, K. Zumbusch, and J. Liebetruth Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study Endoscopy 34 8 2002 611 616
96. W.C. Tan, C. Fulljames, and N. Stone Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia J Photochem Photobiol B 53 1-3 1999 75 80
97. R. Ackroyd, C.J. Kelty, and N.J. Brown Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up Endoscopy 35 6 2003 496 501
98. R. Ackroyd Aminolaevulinic acid-induced photodynamic therapy in the treatment of dysplastic Barrett's oesophagus and adenocarcinoma Lasers Med Sci 14 1999 278 285
99. N.F. Jamieson Photodynamic therapy to eradicate dysplasia and early carcinoma in Barrett's oesphagus Gut 50 2002 A6
100. C.J. Kelty Photodynamic therapy (PDT) for Barrett's oesophagus: establishing the optimum dose of 5-aminolaevulinic acid (ALA) Gut 50 Suppl. 1 2002 123
101. C. Kelty, R. Ackroyd, and N. Brown Enodscopic ablation of Barrett's oesophagus: a randomised trial of photodynamic therapy (PDT) versus argon plasma coagulation (APC) Gut A55 2004 209
102. M. Hage, P.D. Siersema, and H. van Dekken 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial Gut 53 6 2004 785 790
103. R.J. Pacifico, K.K. Wang, and L.M. Wongkeesong Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus Clin Gastroenterol Hepatol 1 4 2003 252 257
104. E.Y. Rahmani, C. Turpin, and Arney K Photodynamic therapy for dysplastic Barrett's esophagus and early esophageal adenocarcinoma should be first line therapy! Gastrointest Endosc 59 2004 pAB250
105. F. Peters, M. Kara, and W. Rosmolen Endoscopic resection combined with photodynamic therapy for high grade dysplasia and early cancer in Barrett's esophagus Gastrointest Endosc 59 2004 pAB251
106. J. Haringsma, P. Siersema, and E. Kuipers Endoscopic ablation of Barrett's neoplasia, Rotterdam results Gastrointest Endosc 59 2004 pAB252